Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey-Reference-Cited by-同舟云学术

Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey

Published:2014-11-06 Issue:1 Volume:41 Page:65-76
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ruhl C. E.¹,Everhart J. E.²

Affiliation:

1. Social & Scientific Systems, Inc.; Silver Spring MD USA

2. Department of Health and Human Services; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda MD USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13012/fullpdf

Reference58 articles.

1. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994;Lazo;Am J Epidemiol,2013

2. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study;Bedogni;Hepatology,2005

3. Italian Statistical Institute http://en.istat.it/

4. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population;Bedogni;BMC Gastroenterol,2006

5. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up;Calori;Hepatology,2011

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring flavonoid intake and all-cause mortality in diverse health conditions: Insights from NHANES 2007–2010 and 2017–2018;Nutrition;2024-11

2. High sucrose diet-induced abnormal lipid metabolism in mice is related to the dysbiosis of gut microbiota;Clinical Nutrition ESPEN;2024-10

3. Trends of chronic liver diseases by income level and socioeconomic factors in the United States: A population‐based study;Alimentary Pharmacology & Therapeutics;2024-09-05

4. Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007–2018;Frontiers in Nutrition;2024-09-04

5. The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease;Annals of Hepatology;2024-09